{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:59:54Z","timestamp":1790355594799,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1111,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Medical Research Council","doi-asserted-by":"crossref","award":["60701235"],"award-info":[{"award-number":["60701235"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.vaccine.2010.05.075","type":"journal-article","created":{"date-parts":[[2010,6,16]],"date-time":"2010-06-16T04:22:30Z","timestamp":1276662150000},"page":"5179-5184","source":"Crossref","is-referenced-by-count":17,"title":["Nasal associated lymphoid tissue (NALT) contributes little to protection against aerosol challenge with Mycobacterium tuberculosis after immunisation with a recombinant adenoviral vaccine"],"prefix":"10.1016","volume":"28","author":[{"given":"Edward O.","family":"Ronan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian Ni","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elma Z.","family":"Tchilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.L.","family":"Beverley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.05.075_bib1","series-title":"Epidemiology, strategy and financing. WHO report 2009","author":"Global tuberculosis control","year":"2009"},{"issue":"3","key":"10.1016\/j.vaccine.2010.05.075_bib2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.coi.2009.05.017","article-title":"Tuberculosis vaccine research: the impact of immunology","volume":"21","author":"Barker","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2010.05.075_bib3","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1128\/IAI.00517-06","article-title":"Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis","volume":"74","author":"Santosuosso","year":"2006","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2010.05.075_bib4","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","volume":"173","author":"Wang","year":"2004","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2010.05.075_bib5","doi-asserted-by":"crossref","first-page":"e5856","DOI":"10.1371\/journal.pone.0005856","article-title":"Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis","volume":"4","author":"Xing","year":"2009","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.vaccine.2010.05.075_bib6","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.4049\/jimmunol.181.7.4955","article-title":"Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice","volume":"181","author":"Forbes","year":"2008","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2010.05.075_bib7","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.4049\/jimmunol.178.4.2387","article-title":"Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization","volume":"178","author":"Santosuosso","year":"2007","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2010.05.075_bib8","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.4049\/jimmunol.174.12.7986","article-title":"Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen","volume":"174","author":"Santosuosso","year":"2005","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2010.05.075_bib9","doi-asserted-by":"crossref","first-page":"e8235","DOI":"10.1371\/journal.pone.0008235","article-title":"Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection","volume":"4","author":"Ronan","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2010.05.075_bib10","article-title":"Murine airway luminal anti-tuberculosis memory CD8 T cells by mucosal immunization are maintained via antigen-driven in situ proliferation, independent of peripheral T cell recruitment","author":"Jeyanathan","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2010.05.075_bib11","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.4049\/jimmunol.168.4.1796","article-title":"Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses","volume":"168","author":"Zuercher","year":"2002","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2010.05.075_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT- versus Peyer's-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2010.05.075_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.0105-2896.2005.00299.x","article-title":"Bronchus- and nasal-associated lymphoid tissues","volume":"206","author":"Bienenstock","year":"2005","journal-title":"Immunol Rev"},{"issue":"12","key":"10.1016\/j.vaccine.2010.05.075_bib14","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.vaccine.2008.01.027","article-title":"Intranasal vaccination of infant mice induces protective immunity in the absence of nasal-associated lymphoid tissue","volume":"26","author":"Sabirov","year":"2008","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2010.05.075_bib15","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.4049\/jimmunol.175.5.3186","article-title":"Upper respiratory tract resistance to influenza infection is not prevented by the absence of either nasal-associated lymphoid tissue or cervical lymph nodes","volume":"175","author":"Wiley","year":"2005","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2010.05.075_bib16","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.4049\/jimmunol.152.4.1653","article-title":"Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity","volume":"152","author":"Liang","year":"1994","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.05.075_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S0950268896007157","article-title":"A simple device for the exposure of animals to infectious microorganisms by the airborne route","volume":"118","author":"Phillpotts","year":"1997","journal-title":"Epidemiol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2010.05.075_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2567.2007.02641.x","article-title":"The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response","volume":"122","author":"Minne","year":"2007","journal-title":"Immunology"},{"issue":"43","key":"10.1016\/j.vaccine.2010.05.075_bib19","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1016\/j.vaccine.2005.05.040","article-title":"Inhalative vaccination with pneumococcal polysaccharide in healthy volunteers","volume":"23","author":"Menzel","year":"2005","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2010.05.075_bib20","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1128\/IAI.13.3.696-703.1976","article-title":"Responses of mice immunised with Influenza virus by aerosol and parenteral routes","volume":"13","author":"Scott","year":"1976","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2010.05.075_bib21","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.4049\/jimmunol.167.6.3293","article-title":"Antigen-specific CD8 (+) T cells persist in the upper respiratory tract following influenza virus infection","volume":"167","author":"Wiley","year":"2001","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2010.05.075_bib22","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/blood-2007-02-062117","article-title":"Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines","volume":"110","author":"Tatsis","year":"2007","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.vaccine.2010.05.075_bib23","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","article-title":"Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells","volume":"182","author":"Lindenstrom","year":"2009","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2010.05.075_bib24","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.vaccine.2010.05.075_bib25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2010.05.075_bib26","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1128\/IAI.00287-09","article-title":"Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis","volume":"77","author":"Vordermeier","year":"2009","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2010.05.075_bib27","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"Betts","year":"2006","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.vaccine.2010.05.075_bib28","doi-asserted-by":"crossref","first-page":"12071","DOI":"10.1128\/JVI.01261-07","article-title":"Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines","volume":"81","author":"Kannanganat","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.05.075_bib29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.05.075_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cyto.2007.11.022","article-title":"IL-23 and IL-17 in tuberculosis","volume":"41","author":"Khader","year":"2008","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.vaccine.2010.05.075_bib31","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1586\/14760584.7.8.1165","article-title":"Lessons for tuberculosis vaccines from respiratory virus infection","volume":"7","author":"Beverley","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"4\u20135","key":"10.1016\/j.vaccine.2010.05.075_bib32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/08820131003729927","article-title":"Mucosal decisions: tolerance and responsiveness at mucosal surfaces","volume":"39","author":"Russell","year":"2010","journal-title":"Immunol Invest"},{"issue":"12","key":"10.1016\/j.vaccine.2010.05.075_bib33","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1073\/pnas.0800043105","article-title":"Immunization by a bacterial aerosol","volume":"105","author":"Garcia-Contreras","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2010.05.075_bib34","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/eji.200535493","article-title":"Intranasal immunisation with inactivated RSV and bacterial adjuvants induces mucosal protection and abrogates eosinophilia upon challenge","volume":"36","author":"Etchart","year":"2006","journal-title":"Eur J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2010.05.075_bib35","doi-asserted-by":"crossref","first-page":"e6999","DOI":"10.1371\/journal.pone.0006999","article-title":"Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin","volume":"4","author":"Lewis","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2010.05.075_bib36","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10007991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10007991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:21:35Z","timestamp":1740165695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10007991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":36,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0264410X10007991"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.05.075","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}